AI Tech Suite

NeuroBlu Analytics

Click to visit website

About

NeuroBlu Analytics is a cutting-edge data analytics solution developed by Holmusk, specifically designed for behavioral health research and care. It enables access to the largest de-identified real-world data source on behavioral health conditions and treatments, powering analysis with over 32 million patients across diverse health systems and exhibiting over 20 years of longitudinal data. The platform utilizes natural language processing (NLP) to enrich this data, allowing researchers to explore patient emotions, cognition, and behaviors that often go unrecorded in traditional Electronic Health Records (EHR). NeuroBlu Analytics empowers different stakeholders, including pharmaceutical companies, academic institutions, and health systems, to conduct studies with ease using user-friendly tools and no-code analytics capabilities. It supports evidence generation around behavioral health treatments, improves outcomes through better patient identification for clinical trials, and accelerates medication development and regulatory approvals. The suite features analytics capabilities, cohort exploration, and collaboration tools, tailored to help users derive insights quickly and effectively.

Features

• dynamic visualizations

• user-friendly data analytics software

• nlp-enriched real-world data

• longitudinal data tracking

• cohort exploration tool

• no-code analytics capabilities

• collaboration and sharing features

• pre-designed study templates

FAQs

What is NeuroBlu Analytics?

NeuroBlu Analytics is a data analytics software specifically designed for behavioral health research, providing access to real-world data.

Who can benefit from using NeuroBlu Analytics?

Healthcare organizations, pharmaceutical companies, academic institutions, and regulatory bodies can benefit from using NeuroBlu Analytics.

What types of data does the platform provide?

The platform provides access to a vast database of de-identified real-world data on behavioral health conditions, symptoms, and pharmacological treatments.